September 3, 2024
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The purpose of this notice is to inform applicants of the early termination, effective immediately, of RFA-DK-25-001: Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional).
The final receipt date, March 20, 2025 has been canceled.
The following sections in Part 1. Overview Information, Key Dates section have been changed:
Currently, reads:
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
Not Applicable | Not Applicable | March 20, 2024 | July 2024 | October 2024 | December 2024 |
Not Applicable | Not Applicable | March 20, 2025 | July 2025 | October 2025 | December 2025 |
Modified to read:
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
Not Applicable | Not Applicable | March 20, 2024 | July 2024 | October 2024 | December 2024 |
All other aspects of this Notice of Funding Opportunity stay the same.
Please direct all inquiries to:
Peter J. Perrin, Ph.D.
Division of Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-3759
Email: [email protected]